At an estimated R27 billion per year, the cost of corruption equates to about 10% of the country’s total budget for health in 2022. With procurement understood to be a government’s single greatest corruption risk – health contracts are especially vulnerable. This is why reform related to safeguarding public procurement and resources is now beyond urgent, argues Zukiswa Kota.
There is nothing humans can do about the fact that everyone dies eventually, but there may be room to do better when it comes to how some doctors, nurses, and care workers break the news of dying and death; and also how they give practical support to a grieving family. Ufrieda Ho looks at what measures are in place to guide healthcare workers, patients, and their families through this process in health facilities.
In January, Cape Town-based biotechnology company Afrigen Biologics announced that it has successfully produced a lab-scale batch of a mRNA vaccine against COVID-19 that is similar to that made by pharmaceutical company Moderna. Catherine Tomlinson takes an in-depth look at how Afrigen managed to reach this point and what further challenges have to be overcome before mRNA vaccines can be produced at scale in South Africa
Hospitals in South Africa have been put under immense strain over the past two years as beds were filled with COVID-19 patients and elective surgeries had to be put on hold. To make things worse, pre-existing shortages of intensive care trained nurses and other critical staff were exacerbated by healthcare workers themselves contracting SARS-CoV-2 and falling ill or having to isolate themselves. Tiyese Jeranji explores how Gauteng and the Western Cape are catching up on elective surgeries and asks what is being done about the underlying problem of staff shortages.
Early in South Africa’s fourth COVID-19 wave, dominated by the Omicron variant, concerns were raised on what appeared to be an increase in hospitalisations among children. A few months on, Elri Voigt asks local experts what we have learnt about the Omicron variant in children.
This week, South Africa’s COVID-19 regulations were amended to state that people who have tested positive for SARS-CoV-2 who do not have symptoms do not have to self-isolate. People who have tested positive and who do have COVID-19 symptoms have to isolate for seven days unless a longer period is recommended by a medical practitioner. Chris Bateman spoke to some local experts about the reasoning behind the changes and what other changes may be warranted.
An innovative new technology that allows women to collect their own samples for HPV testing, rather than having the sample taken by a healthcare worker, was recently tested in the Eastern Cape. Elri Voigt spoke to local experts about the study and what such a self-collected test might mean for cervical cancer detection in South Africa.
As was the case in the rest of the country, the COVID-19 pandemic dealt a severe blow to the tuberculosis (TB) response in the Free State. Refilwe Mochoari gathered the available numbers and asked the province’s health department about their plans to get the TB response back on track.
Whether it is in the queue outside a community healthcare clinic, in a GP’s waiting room, or in the ICU at a private sector hospital, infections acquired at healthcare facilities pose a threat to people’s health. Nthusang Lefafa looks at government’s recently relaunched infection prevention and control plans and some obstacles to its implementation.
It wasn’t rocket science when we predicted at the start of 2021 that South Africa’s biggest challenge this year would be to get COVID-19 shots into as many arms as possible. But the way it has played out with multiple setbacks and scrambling problem-solving is not something anyone could have predicted. In fewer than a thousand words, Spotlight editor Marcus Low takes a look back at a tumultuous year in health in South Africa.
The COVID-19 pandemic and associated lockdowns have dealt a severe blow to South Africa’s tuberculosis (TB) response. Tiyese Jeranji asked government about its plans to get TB diagnosis, treatment, and prevention services back on track.
Unlike regulators in the United States and Europe, the South African Health Products Regulatory Authority has not yet given the green light for any form of mix-and-match COVID-19 vaccine boosting. We take a look at the regulatory issues standing in the way of people in South Africa who received the Johnson & Johnson jab being offered Pfizer boosters.
